TABLE 2.
CD | UC | Non-IBD | Prevalence in CDa | Prevalence in UCa | Prevalence in Non-IBDa | PR in CD vs Non-IBD | PR in UC vs Non-IBD | PR in CD vs UC | |
---|---|---|---|---|---|---|---|---|---|
Overall OI | 27,300 | 24,690 | 2,465,010 | 17,809.4 | 19,208.0 | 7015.2 | 2.54; 95% CI, 2.51–2.57; P < 0.0001 | 2.74; 95% CI, 2.71–2.77; P < 0.0001 | 0.93; 95% CI, 0.91–0.94; P < 0.0001 |
All fungal | 9350 | 7630 | 719,570 | 6099.5 | 5935.9 | 2047.8 | 2.98; 95% CI, 2.92–3.04; P < 0.0001 | 2.90; 95% CI, 2.84–2.96; P < 0.0001 | 1.03; 95% CI, 1.00–1.06; P = 0.069 |
All bacterial | 4720 | 5630 | 126,190 | 3079.1 | 4390.0 | 359.1 | 8.54; 95% CI, 8.33–8.82; P < 0.0001 | 12.20; 95% CI, 11.88–12.52; P < 0.0001 | 0.70; 95% CI, 0.68–0.73; P < 0.0001 |
All viral | 13,230 | 11,430 | 1,619,250 | 8630.7 | 8892.2 | 4608.2 | 1.87; 95% CI, 1.84–1.90; P < 0.0001 | 1.93; 95% CI, 1.90–1.96; P < 0.0001 | 0.97; 95% CI, 0.95–0.99; P = 0.014 |
aPrevalence reported per 100,000.